195 related articles for article (PubMed ID: 24333506)
1. The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility.
Khalil BD; Hanna S; Saykali BA; El-Sitt S; Nasrallah A; Marston D; El-Sabban M; Hahn KM; Symons M; El-Sibai M
Exp Cell Res; 2014 Feb; 321(2):109-22. PubMed ID: 24333506
[TBL] [Abstract][Full Text] [Related]
2. Effect of StarD13 on colorectal cancer proliferation, motility and invasion.
Nasrallah A; Saykali B; Al Dimassi S; Khoury N; Hanna S; El-Sibai M
Oncol Rep; 2014 Jan; 31(1):505-15. PubMed ID: 24253896
[TBL] [Abstract][Full Text] [Related]
3. DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma.
El-Sitt S; Khalil BD; Hanna S; El-Sabban M; Fakhreddine N; El-Sibai M
Oncol Rep; 2012 Aug; 28(2):511-8. PubMed ID: 22614672
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.
Al Haddad M; El-Rif R; Hanna S; Jaafar L; Dennaoui R; Abdellatef S; Miskolci V; Cox D; Hodgson L; El-Sibai M
Cell Commun Signal; 2020 Sep; 18(1):144. PubMed ID: 32900380
[TBL] [Abstract][Full Text] [Related]
5. StarD13 differentially regulates migration and invasion in prostate cancer cells.
Jaafar L; Fakhoury I; Saab S; El-Hajjar L; Abou-Kheir W; El-Sibai M
Hum Cell; 2021 Mar; 34(2):607-623. PubMed ID: 33420961
[TBL] [Abstract][Full Text] [Related]
6. StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion.
Hanna S; Khalil B; Nasrallah A; Saykali BA; Sobh R; Nasser S; El-Sibai M
Int J Oncol; 2014 May; 44(5):1499-511. PubMed ID: 24627003
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology.
Kawai K; Iwamae Y; Yamaga M; Kiyota M; Ishii H; Hirata H; Homma Y; Yagisawa H
Genes Cells; 2009 Feb; 14(2):227-41. PubMed ID: 19170769
[TBL] [Abstract][Full Text] [Related]
8. RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells.
El-Sibai M; Pertz O; Pang H; Yip SC; Lorenz M; Symons M; Condeelis JS; Hahn KM; Backer JM
Exp Cell Res; 2008 Apr; 314(7):1540-52. PubMed ID: 18316075
[TBL] [Abstract][Full Text] [Related]
9. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
[TBL] [Abstract][Full Text] [Related]
10. Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells.
Quick Q; Skalli O
Exp Cell Res; 2010 Apr; 316(7):1137-47. PubMed ID: 20156433
[TBL] [Abstract][Full Text] [Related]
11. The effect of substrate microtopography on focal adhesion maturation and actin organization via the RhoA/ROCK pathway.
Seo CH; Furukawa K; Montagne K; Jeong H; Ushida T
Biomaterials; 2011 Dec; 32(36):9568-75. PubMed ID: 21925729
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
Aguilar-Rojas A; Huerta-Reyes M; Maya-Núñez G; Arechavaleta-Velásco F; Conn PM; Ulloa-Aguirre A; Valdés J
BMC Cancer; 2012 Nov; 12():550. PubMed ID: 23176180
[TBL] [Abstract][Full Text] [Related]
13. Paxillin-dependent paxillin kinase linker and p21-activated kinase localization to focal adhesions involves a multistep activation pathway.
Brown MC; West KA; Turner CE
Mol Biol Cell; 2002 May; 13(5):1550-65. PubMed ID: 12006652
[TBL] [Abstract][Full Text] [Related]
14. Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activation.
Herrera Abreu MT; Hughes WE; Mele K; Lyons RJ; Rickwood D; Browne BC; Bennett HL; Vallotton P; Brummer T; Daly RJ
Mol Biol Cell; 2011 Jan; 22(1):105-16. PubMed ID: 21118992
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin ligase RNF8 regulates Rho GTPases and promotes cytoskeletal changes and motility in triple-negative breast cancer cells.
Pereira De Carvalho B; Chern YJ; He J; Chan CH
FEBS Lett; 2021 Jan; 595(2):241-252. PubMed ID: 33205415
[TBL] [Abstract][Full Text] [Related]
16. ARHGAP18, a GTPase-activating protein for RhoA, controls cell shape, spreading, and motility.
Maeda M; Hasegawa H; Hyodo T; Ito S; Asano E; Yuang H; Funasaka K; Shimokata K; Hasegawa Y; Hamaguchi M; Senga T
Mol Biol Cell; 2011 Oct; 22(20):3840-52. PubMed ID: 21865595
[TBL] [Abstract][Full Text] [Related]
17. Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.
Tripathi BK; Grant T; Qian X; Zhou M; Mertins P; Wang D; Papageorge AG; Tarasov SG; Hunter KW; Carr SA; Lowy DR
J Cell Biol; 2017 Dec; 216(12):4255-4270. PubMed ID: 29114068
[TBL] [Abstract][Full Text] [Related]
18. p16(ink4a) and retinoic acid modulate rhoA and GFAP expression during induction of a stellate phenotype in U343 MG-A astrocytoma cells.
Langlois A; Lee S; Kim DS; Dirks PB; Rutka JT
Glia; 2002 Oct; 40(1):85-94. PubMed ID: 12237846
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA.
Tabu K; Ohba Y; Suzuki T; Makino Y; Kimura T; Ohnishi A; Sakai M; Watanabe T; Tanaka S; Sawa H
Mol Cancer Res; 2007 Oct; 5(10):1099-109. PubMed ID: 17951409
[TBL] [Abstract][Full Text] [Related]
20. Regulation of focal adhesion kinase activation, breast cancer cell motility, and amoeboid invasion by the RhoA guanine nucleotide exchange factor Net1.
Carr HS; Zuo Y; Oh W; Frost JA
Mol Cell Biol; 2013 Jul; 33(14):2773-86. PubMed ID: 23689132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
